Advanced glycation end-product (AGE) induces apoptosis in human retinal ARPE-19 cells via promoting mitochondrial dysfunction and activating the Fas-FasL signaling

Biosci Biotechnol Biochem. 2016;80(2):250-6. doi: 10.1080/09168451.2015.1095065. Epub 2015 Oct 19.

Abstract

Advanced glycation end-products (AGEs) are extremely accumulated in the retinal vascular and epithelial cells of diabetes mellitus (DM) patients, particularly with diabetic retinopathy (DR). To elucidate the pathogenesis of the AGE-induced toxicity to retinal epithelial cells, we investigated the role of Fas-Fas ligand (FasL) signaling and mitochondrial dysfunction in the AGE-induced apoptosis. Results demonstrated that the AGE-BSA- induced apoptosis of retinal ARPE-19 cells. And the AGE-BSA treatment caused mitochondrial dysfunction, via deregulating the B-cell lymphoma 2 (Bcl-2) signaling. Moreover, the Fas/FasL and its downstreamer Caspase 8 were promoted by the AGE-BSA treatment, and the exogenous α-Fas exacerbated the activation of Caspase 3/8. On the other side, the siRNA-mediated knockdown of Fas/FasL inhibited the AGE-BSA-induced apoptosis. Taken together, we confirmed the activation of Fas-FasL signaling and of mitochondrial dysfunction in the AGE-BSA-promoted apoptosis in retinal ARPE-19 cells, implying the important role of Fas-FasL signaling in the DR in DM.

Keywords: Fas–FasL; advanced glycation end-product (AGE); apoptosis; human retinal cells; mitochondrial dysfunction.

MeSH terms

  • Apoptosis / drug effects*
  • Caspase 3 / genetics
  • Caspase 3 / metabolism
  • Caspase 8 / genetics
  • Caspase 8 / metabolism
  • Cell Line
  • Epithelial Cells / drug effects*
  • Epithelial Cells / metabolism
  • Fas Ligand Protein / agonists
  • Fas Ligand Protein / antagonists & inhibitors
  • Fas Ligand Protein / genetics*
  • Fas Ligand Protein / metabolism
  • Gene Expression Regulation
  • Glycation End Products, Advanced / pharmacology*
  • Humans
  • Membrane Potential, Mitochondrial / drug effects
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Recombinant Fusion Proteins / pharmacology
  • Retina / drug effects
  • Retina / metabolism
  • Serum Albumin, Bovine / pharmacology
  • Signal Transduction
  • fas Receptor / agonists
  • fas Receptor / antagonists & inhibitors
  • fas Receptor / genetics*
  • fas Receptor / metabolism

Substances

  • BCL2 protein, human
  • FAS protein, human
  • FASLG protein, human
  • Fas Ligand Protein
  • Glycation End Products, Advanced
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Small Interfering
  • Recombinant Fusion Proteins
  • fas Receptor
  • Serum Albumin, Bovine
  • Casp3 protein, mouse
  • Casp8 protein, mouse
  • Caspase 3
  • Caspase 8